Graham G. Walmsley
SEC insider (Form 3/4/5 filer). CIK 0001777517. Director at Olema Pharmaceuticals, Inc. (OLMA) and 1 other issuer. 21 reported Form 4/5 transactions since Sep 2024; latest on Jun 18, 2026. Located in SAN FRANCISCO, CA.
Companies Graham G. Walmsley has filed insider reports for
- Olema Pharmaceuticals, Inc. (OLMA): Director
- Akero Therapeutics, Inc. (AKRO): Director
Graham G. Walmsley
CIK: 0001777517
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (21 total)
- Jun 18, 2026OLMA
Olema Pharmaceuticals, Inc.
AwardDirectStock Option (right to buy)
29.5K shares- - Dec 9, 2025AKRO
Akero Therapeutics, Inc.
DispositionDirect9.4K shares- - Dec 9, 2025AKRO
Akero Therapeutics, Inc.
DispositionIndirect1.2M shares- - Dec 9, 2025AKRO
Akero Therapeutics, Inc.
DispositionDirect93K shares- - Oct 8, 2025AKRO
Akero Therapeutics, Inc.
ExerciseDirect26K shares at avg. $23.02$599K - Oct 8, 2025AKRO
Akero Therapeutics, Inc.
ExerciseDirect13K shares at avg. $25.20$328K - Oct 8, 2025AKRO
Akero Therapeutics, Inc.
ExerciseDirect13K shares at avg. $26.32$342K - Oct 8, 2025AKRO
Akero Therapeutics, Inc.
ExerciseDirect15K shares at avg. $8.13$122K - Oct 8, 2025AKRO
Akero Therapeutics, Inc.
ExerciseDirect23.8K shares at avg. $19.97$476K - Jun 11, 2025OLMA
Olema Pharmaceuticals, Inc.
AwardDirectStock Option (right to buy)
24.2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 18, 2026 |  OLMA Olema Pharmaceuticals, Inc. | Award Stock Option (right to buy) | 29,500 | - | - | Direct |
| Dec 9, 2025 |  AKRO Akero Therapeutics, Inc. | Disposition | 9,398 | - | - | Direct |
| Dec 9, 2025 | AKRO Akero Therapeutics, Inc. | Disposition | 1,200,000 | - | - | Indirect |
| Dec 9, 2025 | AKRO Akero Therapeutics, Inc. | Disposition | 93,000 | - | - | Direct |
| Oct 8, 2025 | AKRO Akero Therapeutics, Inc. | Exercise | 26,000 | $23.02 | $598,520 | Direct |
| Oct 8, 2025 | AKRO Akero Therapeutics, Inc. | Exercise | 13,000 | $25.20 | $327,600 | Direct |
| Oct 8, 2025 | AKRO Akero Therapeutics, Inc. | Exercise | 13,000 | $26.32 | $342,160 | Direct |
| Oct 8, 2025 | AKRO Akero Therapeutics, Inc. | Exercise | 15,000 | $8.13 | $121,950 | Direct |
| Oct 8, 2025 | AKRO Akero Therapeutics, Inc. | Exercise | 23,832 | $19.97 | $475,925 | Direct |
| Jun 11, 2025 | OLMA Olema Pharmaceuticals, Inc. | Award Stock Option (right to buy) | 24,150 | - | - | Direct |
1-10 of 21 transactions